Fundraising Fox
Kare Chemical Technologies
Mississauga, CA · 2 known investors
Find your way into Kare Chemical Technologies
Sign up to see every warm intro you have to Kare Chemical Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kare Chemical Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kare Chemical Technologies is a pharmaceutical technology company using a patented catalytic process to convert limonene, a citrus by-product, into high-purity CB1 and CB2 receptor ligands for drug development. It develops non-psychoactive therapeutic candidates aimed at safer alternatives to opioids and next-generation metabolic therapies.
Investors · 2
Ontario Centre of Innovationlisted by Ontario Centre of InnovationToronto · $500K
How we know: Ontario Centre of Innovation's portfolio page · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountPre-SeedOct 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Kare Chemical Technologies do?
- Kare Chemical Technologies is a pharmaceutical technology company using a patented catalytic process to convert limonene, a citrus by-product, into high-purity CB1 and CB2 receptor ligands for drug development. It develops non-psychoactive therapeutic candidates aimed at safer alternatives to opioids and next-generation metabolic therapies.
- Who are Kare Chemical Technologies's investors?
- Kare Chemical Technologies's investors include Ontario Centre of Innovation, Ontario Centre of Innovation programs.
- Where is Kare Chemical Technologies headquartered?
- Kare Chemical Technologies is headquartered in Mississauga, CA.